Mode of action of new multiple sclerosis drug discovered
Just a few short weeks ago, dimethyl fumarate was approved in Europe as a basic therapy for multiple sclerosis. Although its efficacy has been established in clinical studies, its underlying mode of action was still unknown, ...
Apr 1, 2014
0
0